Catalysts for Lupin Ltd
146 tracked
Aug 13, 2025
recall
AEQUITA PHARMACY recall (Cls II)
Lupin Ltd
→
Aug 13, 2025
recall
AEQUITA PHARMACY recall (Cls II)
Lupin Ltd
→
Aug 13, 2025
recall
AEQUITA PHARMACY recall (Cls II)
Lupin Ltd
→
Jul 2, 2025
recall
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) recall (Cls II)
Lupin Ltd
→
Jul 2, 2025
recall
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) recall (Cls II)
Lupin Ltd
→
Jul 2, 2025
recall
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) recall (Cls II)
Lupin Ltd
→
Oct 31, 2024
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Oct 31, 2024
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Oct 31, 2024
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Oct 31, 2024
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
naloxone hydrochloride
→
Jul 30, 2024
approval
ANTARA (MICRONIZED) (FENOFIBRATE) — FDA approval
FENOFIBRATE
→
Jan 3, 2024
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
naloxone hydrochloride
→
Jan 3, 2024
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
naloxone hydrochloride
→
Dec 15, 2023
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Dec 15, 2023
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Dec 15, 2023
approval
TRAMADOL HYDROCHLORIDE — FDA approval
tramadol hydrochloride ER
→
Dec 15, 2023
approval
NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA approval
Lupin Ltd
→
Dec 4, 2023
approval
VARENICLINE TARTRATE — FDA approval
VARENICLINE TARTRATE
→
Jul 31, 2023
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Mar 30, 2023
approval
ZIPRASIDONE HYDROCHLORIDE — FDA approval
Lupin Ltd
→
Mar 30, 2023
approval
ZIPRASIDONE HYDROCHLORIDE — FDA approval
Lupin Ltd
→
Mar 30, 2023
approval
ZIPRASIDONE HYDROCHLORIDE — FDA approval
Lupin Ltd
→
Sep 28, 2022
approval
MIRABEGRON — FDA approval
mirabegron ER
→
Sep 14, 2022
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Sep 14, 2022
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Sep 14, 2022
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 10, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 10, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 10, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jun 10, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→